Sector News

Pilot Chemical names president to head investment strategy

March 15, 2019
Chemical Value Chain

Pilot Chemical, a maker of cleaning and metalworking chemicals, has named Mike Clark, currently the company’s COO, as president. Clark will oversee implementation of Pilot’s investment strategy, and continue to report to Pilot CEO Pam Butcher.

Pilot plans to “invest millions in the development and commercialization of new technologies over then next four years.” This includes the expansion of Pilot’s facility at Middletown, Ohio, to test and validate technologies prior to commercialization. It also includes investment in recruiting talent, digitalizing operations, and information technology upgrades.

“Mike brings fresh eyes and experience with turning strategy into operational and financial success,” Butcher says.

As part of the shift, Catherine Ochterski has been named vice president/human resources; Mike Bizzaro has been named director/manufacturing; David Waismann has been named director/digitalization; and Mark Moser has been named director/information technology.

By Vincent Valk

Source: Chemical Week

Join the discussion!

Your email address will not be published. Required fields are marked *

Related News

January 10, 2021

TechnipFMC resumes plans to split company

Chemical Value Chain

TechnipFMC says it has resumed activities related to the previous announced separation of the company into two separate pure-play businesses, TechnipFMC and Technip Energies.

January 10, 2021

Solvay’s extended maternity, paternity & co-parent policy goes into effect

Chemical Value Chain

Solvay’s new policy increases maternity leave to 16 weeks. It is now available to any co-parent regardless of gender or sexual orientation; it also includes parents who adopt. The parent employed by Solvay will receive 100% of his or her salary during this leave period.

January 10, 2021

Solvay to sell its North American and European amphoteric surfactant business 

Chemical Value Chain

The Solvay Group (Brussels, Belgium) agreed to sell its North American and European amphoteric surfactant business to OpenGate Capital, a private equity firm with headquarters in Los Angeles. The sale includes the three main production sites in University Park, Illinois (USA), Genthin, Germany, Halifax, United Kingdom, and a tolling business in Turkey.

Send this to a friend